122 related articles for article (PubMed ID: 18641877)
1. Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters.
Meurer RT; Martins DT; Hilbig A; Ribeiro Mde C; Roehe AV; Barbosa-Coutinho LM; Fernandes Mda C
Arq Neuropsiquiatr; 2008 Jun; 66(2B):385-90. PubMed ID: 18641877
[TBL] [Abstract][Full Text] [Related]
2. Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
Woodburn RT; Azzarelli B; Montebello JF; Goss IE
J Neurooncol; 2001 Mar; 52(1):57-62. PubMed ID: 11451203
[TBL] [Abstract][Full Text] [Related]
3. TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas.
Ohta T; Watanabe T; Katayama Y; Kurihara J; Yoshino A; Nishimoto H; Kishimoto H
Neuropathology; 2006 Jun; 26(3):170-7. PubMed ID: 16771171
[TBL] [Abstract][Full Text] [Related]
4. A clinicobiological model predicting survival in medulloblastoma.
Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
[TBL] [Abstract][Full Text] [Related]
5. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression.
Coffin CM; Braun JT; Wick MR; Dehner LP
Mod Pathol; 1990 Mar; 3(2):164-70. PubMed ID: 2109316
[TBL] [Abstract][Full Text] [Related]
8. Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density.
Miralbell R; Tolnay M; Bieri S; Probst A; Sappino AP; Berchtold W; Pepper MS; Pizzolato G
J Neurooncol; 1999; 45(2):103-10. PubMed ID: 10778725
[TBL] [Abstract][Full Text] [Related]
9. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.
Zhao X; Song T; He Z; Tang L; Zhu Y
Med Oncol; 2010 Sep; 27(3):985-91. PubMed ID: 19806481
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma with extensive nodularity: a variant occurring in the very young-clinicopathological and immunohistochemical study of four cases.
Suresh TN; Santosh V; Yasha TC; Anandh B; Mohanty A; Indiradevi B; Sampath S; Shankar SK
Childs Nerv Syst; 2004 Jan; 20(1):55-60. PubMed ID: 14657995
[TBL] [Abstract][Full Text] [Related]
11. DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation.
Lin JP; Pan BC; Li B; Li Y; Tian XY; Li Z
World J Surg Oncol; 2014 Dec; 12():373. PubMed ID: 25475127
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
Min HS; Lee YJ; Park K; Cho BK; Park SH
Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
[TBL] [Abstract][Full Text] [Related]
13. Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases.
Maraziotis T; Perentes E; Karamitopoulou E; Nakagawa Y; Gessaga EC; Probst A; Frankfurter A
Acta Neuropathol; 1992; 84(4):355-63. PubMed ID: 1441916
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules.
Eberhart CG; Kaufman WE; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2001 May; 60(5):462-9. PubMed ID: 11379821
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.
Son EI; Kim IM; Kim DW; Yim MB; Kang YN; Lee SS; Kwon KY; Suh SI; Kwon TK; Lee JJ; Kim DS; Kim SP
Pathol Int; 2003 Feb; 53(2):67-73. PubMed ID: 12588433
[TBL] [Abstract][Full Text] [Related]
16. Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.
Bartek J; Fornara O; Merchut-Maya JM; Maya-Mendoza A; Rahbar A; Stragliotto G; Broholm H; Svensson M; Sehested A; Söderberg Naucler C; Bartek J; Bartkova J
Mol Oncol; 2017 Aug; 11(8):945-964. PubMed ID: 28383788
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
Schüller U; Schober F; Kretzschmar HA; Herms J
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
[TBL] [Abstract][Full Text] [Related]
18. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma.
Ho DM; Hsu CY; Wong TT; Ting LT; Chiang H
Acta Neuropathol; 2000 May; 99(5):482-8. PubMed ID: 10805090
[TBL] [Abstract][Full Text] [Related]
19. Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts.
He XM; Wikstrand CJ; Friedman HS; Bigner SH; Pleasure S; Trojanowski JQ; Bigner DD
Lab Invest; 1991 Jun; 64(6):833-43. PubMed ID: 1904513
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study.
McLendon RE; Friedman HS; Fuchs HE; Kun LE; Bigner SH
Histopathology; 1999 Feb; 34(2):154-62. PubMed ID: 10064395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
